logo
Best anti-snore pillows to stop snoring in 2025

Best anti-snore pillows to stop snoring in 2025

News.com.au09-05-2025
These products are hand-picked by our team to help make shopping easier. We may receive payments from third parties for sharing this content and when you purchase through links in this article. Product prices and offer details are not assured, and should be confirmed independently with the retailer. Learn more
Everyone snores once in a while but when it's a continuous problem, it can be a massive pain – both for you and your sleeping partner.
Sure, a quick Google search will provide you with an array of options that claim to stop snoring but one of the most effective – and affordable and convenient – ways starts with changing your pillow. That's because during sleep, your airways relax and narrow, and your tongue falls backward. As you breathe, the walls of your throat vibrate and cause the sound of snoring.
Using an anti-snore pillow fixes this issue by adjusting your sleeping position, keeping your airways open, providing spinal alignment and supporting your head and neck.
Anti-snore pillows are available in a variety of shapes and sizes and also offer multiple levels of firmness and support based on your individual needs and preferences. Here, we've compiled a list of the very best ones for every type of snoring sleeper, including the best-selling Ecosa pillow that reviewers say has helped reduce their partner's snoring.
OUR TOP PICKS
EDITOR'S
CushionCare Cervical Memory Foam Pillow, $69.95 at Amazon
CushionCare Cervical Memory Foam Pillow
What You Need To Know
This one gets our top pick based on quality, design and affordability. The therapeutic contour pillow is made from a breathable high-density memory foam core and features an ergonomic design that gently cradles the neck and head, reducing movement throughout the night. Perfect for side, back and stomach sleepers, the pillow also comes with an outer and inner cover to keep the foam clean and prolong its lifespan.
The orthopaedic pillow is marketed as 'the best sleep you'll ever have', which sounds like a big call but is backed by over 1.8k five-star reviewers on Amazon.
'I have searched high and low for a sleeping pillow that would help me sleep,' one reviewer explained. 'Although I have only had the pillow for four days, the Cervical Memory Foam pillow is most comfortable and I have woken up refreshed. I am quite sure that in another two weeks I will still feel I made the right purchase.'
Another satisfied customer wrote: 'When I opened the package I could tell it was good quality and better than my previous pillows. I've tried a few standard-shaped pillows with no relief. But CushionCare neck pillow made a difference on the first night. I slept soundly and comfortably and no more aching neck! I've had it for a month now and it's one of the best purchases I have made.'
What You Need To Know
The Ecosa Pillow is equally as good as the best-selling mattresses the brand is known for. It comes with three bonus memory foam pads for a completely customisable fit, so whether you're a side, back or freestyle sleeper, you can find the ideal head elevation for a restful, snore-free sleep. Plus, its ergonomic, contoured design promotes neck and spine alignment, promoting a neutral posture that reduces pain and again, unwanted snoring. The innovative pillow also comes with a handy vacuum seal and travel bag, so you never have to go a night without resting your head on your favourite bedding item.
With free shipping and a 100-night trial, you can finally rest easy just like the other 12.6k five-star customers.
One reviewer who uses a CPAP (continuous positive airway pressure) machine, wrote the following: 'I am a CPAP user with sleep apnoea, and this is my second Ecosa pillow purchase. These pillows are perfect for side sleepers. I had to convert myself to side sleeping beyond age 50 because of shoulder pain and acid reflux, and this amazing pillow has made the difference. I love putting the thicker side under my neck for the amazing support it gives.'
A second person simply said, 'My husband loves his new pillow and has even reduced his snoring and tossing.'
Picture: Amazon Australia.
What You Need To Know
If you're willing to spend some money on a high-quality memory foam pillow to help you stop snoring, the TEMPUR-Ergo Neck Pillow is a safe choice. The 'expertly engineered' ergonomic design is meant to help support your head, neck and shoulders while you sleep, with many customers revealing their partners stopped snoring upon snoozing on it.
'The pillow itself is very comfortable to sleep on,' one person wrote. 'My wife says I snore less with this new pillow.'
One of the 4.2k five-star reviewers commented on the pillow's ability to relieve bodily pains, writing, 'This pillow is amazing! It is firm, but soft and really holds its shape. I have sooooo many neck and back issues and am a side sleeper. I can definitely tell the difference in my neck just a week into use.'
The pillow also comes with a removable hypo-allergenic polyester cover for a fresh sleep, night after night.
While returns or refunds aren't allowed, the pillow does come with a five-year warranty.
Dentons Anti-Snore Pillow, $169.95 at Amazon
Dentons Anti-Snore Pillow
What You Need To Know
You know a pillow that's recommended by chiropractors and physiotherapists is going to be a worthwhile investment. It's made from the brand's signature patented Softec foam, which has a higher degree of open cell formation for better breathability, resulting in a cooler foam and better night's sleep (read: snore-free snooze). The contoured variations of this Dentons number are specifically designed for back sleepers looking for optimal comfort and superior neck support to increase airflow and reduce snoring.
One customer who was recommended the pillow by their chiropractor, wrote, 'The best pillow I have bought, great support for my head and neck, I have used around 10 months now no more neck pain on my wake up in the morning.'
Another satisfied sleeper said: 'I'm amazed at how well it worked. My husband stopped snoring and started sleeping through the night. Thank you!!'
Unfortunately, Dentons doesn't offer refunds or exchanges for change of mind but they do offer a five-year guarantee, which covers product faults and defects.
The Eva Pillow, $149 at Eva
What You Need To Know
The simple design of The Eva Pillow makes it a versatile pick for all types of sleepers, especially with its customisable build. If you love a super plush pillow, remove the cover for softer relief and for those needing extra support, simply leave the cover on for a firmer pillow.
Eva also says the pillow won't lose its shape or sag in the centre like a sad pavlova. Instead, it'll retain its shape without sacrificing the 'cloudlike' feeling. And despite its sturdy foam, it's also incredibly breathable thanks to the expertly designed airflow holes and the fact that it's been activated with charcoal to regulate moisture, remove odours and keep bad bacteria at bay.
'We've been using the Eva pillows since April 2022 and honestly they've changed our lives,' one person admitted. 'We were starting to think sore necks were a part of life but that was because we weren't sleeping on the Eva pillow. Since the first night we used them we've woken every morning without any pain and actually feeling like we got a nights sleep!'
A second person wrote: 'Tried two other pillows before purchasing the Eva pillow. The Eva is soft and comfortable, no more stiff neck in the morning.'
White Cool Gel Memory Foam Wedge Pillow with Cover
What You Need To Know
The White Cool Gel Memory Foam Wedge is designed to lift the upper body while accommodating the sleeper's shape to reduce airway compression from gravity without creating acute pressure points.
It comes in four different thicknesses – 10cm, 19cm, 25cm and 30cm – so there's a perfect height for everyone. It has a moderate firmness feel and is constructed of cool gel memory foam with a bamboo fibre cover for hypo-allergenic properties and longer-lasting durability.
The wedge shape is best suited for back sleepers, however, plenty of side sleepers have reported enjoying this design, too. As an added bonus, it doubles as a laptop, arm, book or phone stand when lounging on the sofa or a leg rest after a long day of standing.
A five star reviewer commented, 'I use them in bed at home, and in our caravan. Really helps us get a better nights sleep by elevating our heads in a more comfortable way than just pillows.'
Another person simply said, 'Great product! Very helpful for when you have a cold or elevation.'
on sale
Picture: Myer.
What You Need To Know
This medium-profile pillow is a side sleeper's dream. It features a hypo-allergenic fill, making it perfect for asthma and allergy sufferers and has a luxurious cotton sateen cover that finesses the overall high quality of the pillow.
The Heritage Side Sleeper has attracted rave reviews, with most people praising the product for its support, quality and affordable price tag.
'Most comfortable pillow I have ever owned. Great price too. Cannot fault it. If you have neck pain/headaches or acid reflux, get this pillow,' a five-star reviewer explained.
Another person admitted: 'Heritage Pillows are my favourite pillows and retain their loft for a considerable length of time. They are washable and durable and good value for money.'
The Koala Pillow, $155 at Koala
The Koala Pillow
Picture: Koala.
$155 at Koala
What You Need To Know
The brand that's loved for its sofas and mattresses brings an anti-snore pillow set to rival the very best on the global market. No joke, because the Koala Pillow holds the title of the 2021 and 2022 Canstar Blue 'Most Satisfied Customers' Award in the pillow category.
The brand's VP of Product Design, James Whitta, explained exactly why this sleep expert-approved pillow with over 3.5k five-star reviews, is an essential investment for those who snore.
'Our award-winning Koala pillow utilises gel-infused memory foam offering both a firm and soft side, so you can flip it to the side you like best,' Whitta told news.com.au. 'The dual sides means the Koala Pillow suits everyone from side sleepers, stomach sleepers, back sleepers, even combination sleepers – and assists with comfort to help minimise snoring.'
Koala also offers fast and free delivery as well as a 120-night trial period and a one-year warranty.
But when you purchase a Koala pillow, you're not just doing yourself (and your sleeping partner) a favour — you're also benefiting the environment. That's because Koala is the only Australian furniture retailer that annually gives away one per cent of gross sales for the good of the planet. The company is also B-corp certified and belongs to a group of companies that work together to build a more sustainable economy, plus, they've partnered with the World Wildlife Fund so every pillow purchased helps protect Australian koalas.
What You Need To Know
Many experts believe sleeping in a cooler room can benefits snorers, so it makes sense to opt for a pillow that regulates temperature and reduces the likelihood of the sleeper overheating and waking up sweating. That's why the Emma Foam Pillow is the perfect long-term investment for snorers. It's crafted with a opened pored memory foam that enhances air flow and absorbs moisture along with the breathable top cover that's machine washable.
Another standout feature is the adjustable height and firmness levels. For those who prefer to sleep on their stomach, you can stick to just using one layer. Back sleepers can choose between two or three layers, while side sleepers are recommended to use all three layers for ultimate support and comfort.
'After a week of sleeping on our new pillows, no more sore neck a better night's sleep. Also I have been told by my partner that my snoring has definitely decreased too, ' praised a shopper on Product Review.
Yes, the Emma Foam Pillow is on the higher price of anti-snore pillows, however, Emma is confident you'll fall in love with that they offer free delivery, a 150-night trial and free returns.
on sale
Habitat Travel & Camping Memory Foam Pillow
Picture: Pillow Talk.
What You Need To Know
It's inconvenient to carry around a bulky pillow on your travels, which is why you need this compact anti-snore pillow from Habitat that also comes with a handy travel bag.
Although smaller in size, it's still made with memory foam that contours softly around the head and helps align the body into full relaxation mode. The foam is also infused with bamboo charcoal, which helps eliminate odours, absorb moisture and keep the pillow fresh. Ventilated airflow holes regulate heat and help keep you cool as you sleep while travelling by train, car, plane, cruise or when camping.
One reviewer wrote: 'The quality and comfort in this pillow has beaten two other options I have purchased over the years. So happy.'
WHAT SHOULD YOU LOOK FOR WHEN BUYING ANTI-SNORE PILLOWS
Sleep Position and Support
The way your pillow supports your head, neck, and spine plays a major role in how effectively it can reduce snoring.
Back sleepers may find their head tilts backward or forward, which can cause the tongue to fall back and block the airway. A pillow that gently elevates the head and supports the neck can help prevent this.
• Side sleepers typically benefit from a pillow that aligns the neck and spine while keeping the airway open.
• Stomach sleepers are typically advised to choose a thin memory foam pillow that offers minimal elevation to avoid neck strain and reduce obstruction.
Firmness
Firmness is a matter of personal preference, some people prefer a firmer pillow for more support, while others like a softer feel. If you're unsure, look for a pillow with adjustable firmness or one you can trial at home.
Materials
Anti-snore pillows come in a range of materials including memory foam, latex, and hybrid fills. You can also find pillows with hypo-allergenic covers and cooling features, which may help improve overall sleep quality and comfort, especially for sensitive sleepers. Ultimately, the right choice comes down to your personal preferences and sleep needs.
Price
Anti-snore pillows are available at a variety of price points, from more budget-friendly options to premium models. The right choice is one that fits your budget while effectively improving your sleep posture and helping reduce snoring.
HOW WE CHOOSE PRODUCTS
To help you find the best anti-snore pillow for your needs and budget, we asked leading General Practitioner, Dr Michela Sorensen, and Dr Paul Coceancig, Maxillofacial Surgeon and Sleep Apnoea Expert, for their expert advice and recommendations on what to look for when buying an anti-snore pillow. In addition, our shopping team read hundreds of customer reviews and looked at test results and ratings from product review sites to find the best anti-snore pillow from premium to budget to help you find the right one.
FREQUENTLY ASKED QUESTIONS
HOW DO ANTI-SNORE PILLOWS WORK?
Anti-snore pillows are ergonomically designed to support your neck and head to keep your airways as open as possible. They can also alter your sleeping position and keep you sleeping on your side, which benefits those who snore because they sleep flat on their back.
Many anti-snore pillows are made with polyurethane, which is the building block of memory foam and is strong enough to keep you in position while providing support and comfort.
The shape of anti-snore pillows is generally lower in the centre and higher on the sides, and some even have a cutout to stop you from rolling onto your back.
It's important to note that anti-snore pillows act more like a Band-Aid for snoring problems, as opposed to directly addressing the root cause. If you, or someone you know, suffers from snoring, it's crucial to look into active lifestyle solutions like losing weight, quitting smoking, avoiding alcohol at least four hours before bedtime or treating allergies.
HOW DO YOU STOP SNORING AT NIGHT?
Stopping snoring is not a one-size-fits-all approach, explained Dr Sorensen.
'It depends on the underlying cause of your snoring.'
If you're a regular snorer, you should consult a doctor who will be able to review your signs and symptoms and perform a medical examination so they can recommend the best treatments for your case.
According to Healthdirect and Dr Sorensen, simple measures that might help include:
Losing weight with diet and fitness changes
Avoiding alcohol and sedatives close to bedtime
Quitting smoking
Avoiding sleeping on your back
Treating nasal congestion
Getting enough sleep
Trying mouth exercises
Raising the head of your bed or using an elevating pillow
Dr Sorensen added, 'Your doctor may recommend splints or other devices to assist with your jaw position or breathing during sleep.'
You may also be required to use a device that blows air into your nose or mouth while sleeping, Dr Coceancig noted.
Continuous positive airway pressure (CPAP) is the most effective treatment and involves a pump connected to a mask that you wear at night.
'This helps with inflating the collapsed airway behind the collapsing tongue,' Dr Coceancig explained.
Then, there are more invasive treatments.
'Throat surgery performed by ENT surgeons can also help 'bore put the pipes' by removing tonsils or adenoids or opening up the nasal air passages to help with night-time breathing,' Dr Coceancig said.
'If you are seeking a permanent cure, you need to address the primary cause of sleep apnoea, which is almost always a small jaw and the disproportionate facial structures that a small jaw causes.'
WHEN SHOULD YOU WORRY ABOUT SNORING?
Nearly everyone snores occasionally, however, if left untreated or it's an ongoing problem, it can be a symptom of a bigger health problem like obstructive sleep apnoea, explained leading General Practitioner Dr Michela Sorensen.
'The warning signs of when to see a doctor include having apnoeic episodes (when you are gasping for breath in your sleep) or experiencing excessive daytime fatigue that interferes with your normal routine day-to-day activities,' Dr Sorensen told news.com.au.
But regardless of whether snoring is a relatively new habit or a long-term one, snoring is an early sign of developing sleep apnoea, which will impact your health in alarming ways, according to Dr Paul Coceancig, Maxillofacial Surgeon and Sleep Apnoea Expert.
'In the short term, sleep apnoea can result in brain fog, lethargy, hyperactivity, excessive daytime sleepiness, somatic problems and psychological issues,' Dr Coceancig told news.com.au.
'Long term, sleep deficiency has been linked to cardiovascular disease and obesity and can adversely impact your respiratory, digestive and endocrine systems. Some research indicates that sleep apnoea can lower your life expectancy by as much as 15 years.'
'Other causes of snoring can include blocked nasal passages due to illness and alcohol and drug use.'
And it's not just affecting your health, either.
'In addition to the impact on the snorer, snoring can impact relationships, causing frustration, resentment and damaging sleep quality for those in close proximity to the snorer,' Dr Coceancig added.
Snoring is typically more frequent and loudest when sleeping on the back and this is because of gravity, according to Dr Sorensen.
'When you are on your back, gravity pushes the soft structures in your mouth and neck down, narrowing your airway. This causes turbulent airflow resulting in the snoring sound.'
Lastly, never miss another shopping tip, sale or guide – sign up to our newsletter here.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Modern Family star Julie Bowen thought she was ‘gonna die' after her health diagnosis at 29
Modern Family star Julie Bowen thought she was ‘gonna die' after her health diagnosis at 29

News.com.au

time11 hours ago

  • News.com.au

Modern Family star Julie Bowen thought she was ‘gonna die' after her health diagnosis at 29

Julie Bowen is opening up about her health. The Modern Family star, 55, told Michael Rosenbaum on Tuesday's episode of his Inside of You podcast that she has sick sinus syndrome, a type of rhythm disorder that affects the heart's natural pacemaker, per the Mayo Clinic. Bowen's condition is called hypervagotonia, which is increased activity in the vagus nerve, according to the National Institute of Health. 'I have a low resting heart rate,' she explained, noting that her pacemaker is 'set so that it can't go below 45.' Before the pacemaker, Bowen's resting heart rate was in the 30s, when the 'normal' resting heart rate is between 60 to 100 beats per minute for women. The Hysteria! star's sister diagnosed her condition while the two were on a getaway. Bowen shared that her sibling, Annie Luetkemeyer, had just graduated from medical school and 'was at that time in her life when she, I guess, she always carried around a stethoscope. And we were on vacation, and she was like, 'I wanna listen to this.'' 'She was like, 'That is not what they've been telling you, and it's not runner's heart or whatever. That means you need to go to a cardiologist,'' the Happy Gilmore star remembered. 'I was like, 'I'm fine,'' the actress shared, adding that her sister 'would not let it go.' A month later, Bowen shot the pilot for the NBC series Ed alongside Tom Cavanagh. The comedy/drama ran from 2000 to 2004. 'I shot the pilot of Ed and immediately had to go get a pacemaker afterwards,' Bowen said. 'I was like, 'Oh my God. My life is over. This is so weird. I'm gonna die.' I don't know what I thought it was, because I was 29.' 'You're lucky you didn't die before that,' Rosenbaum, 52, responded. 'They said I wouldn't probably die of it, but I'd start passing out,' Bowen clarified. 'There was a vague feeling … whenever I was relaxed, really relaxed, I'd be, like, watching TV or movie.' The Hubie Halloween star described it felt like she'd 'been holding my breath for a while, that feeling of, like, light-headedness. And they said, 'You're gonna be driving a car, and you're gonna pass out, and you're gonna kill somebody.' And I was like, 'Oh, well, then give me the Goddamn pacemaker.'' Bowen has had the batteries replaced three times; however, she admitted, 'I forget about it all the time.' These days, the Boston Legal star hasn't let her condition slow her down one bit. In fact, she's starring in the upcoming sequel to the beloved 1996 sports comedy Happy Gilmore. Bowen is reprising her role as Virginia Venit, the love interest of Adam Sandler's Happy Gilmore, but didn't know if she'd be asked back for round two. 'I thought, 'Well I won't be in it,'' Bowen told The Hollywood Reporter in June. 'And that was OK — it was like Virginia Venit, it's been 30 years, he's got a hottie. He's got some little bitty on the side, like a cart girl,' she continued. 'As a matter of fact my children told me, before I was even told officially that there was a Happy Gilmore sequel, my now 18-year-old said, 'Mum, I hear they're doing a sequel and he's with Sydney Sweeney as a cart girl.'' Bowen teased, 'I went, I'm hurt and I so respect that move. Of course, why wouldn't you? So when I got the call that I was actually in it, I was like, 'Are you sure? Come on.'' Although Sweeney, 27, isn't in the film, the sequel is set to have a slew of new faces, including Bad Bunny, Margaret Qualley, Benny Safdie, Travis Kelce, Kym Whitley and Eminem. 'Seeing Bad Bunny on set I was just like, 'Oh, I can't actually look you in the eye, I'm going to have to walk away,' and I did,' Bowen recalled. 'I think he was offended and I had to circle back and now I made it worse. I'm the kind of person who doesn't want to meet her heroes because I think I'm just going to be a jackass.'

Biocurious: Dimerix could be riding big and beautiful kidney drug success earlier than expected
Biocurious: Dimerix could be riding big and beautiful kidney drug success earlier than expected

News.com.au

time19 hours ago

  • News.com.au

Biocurious: Dimerix could be riding big and beautiful kidney drug success earlier than expected

With the FDA's blessing, Dimerix will use phase III trial endpoints that could lead to accelerated approval for its kidney disease drug Dimerix is confident of phase III success because an expert 'peek' at the blinded data shows it's on the right track The company is well cashed up, courtesy of four global distribution deals When it comes to clinical trials, the choice of primary endpoints can mean the difference between a trial failing and a billion-dollar blockbuster drug emerging. Plenty of drug candidates have looked successful at mid stage, but then floundered because a later stage trial has failed to meet strictly defined goals. This appears to be the case with Opthea (ASX:OPT) and the recent failure of its two phase III eye disease trials. In other cases, strictly enforced endpoints mean that a trial is too long and too expensive. But regulatory attitudes are changing. In the case of Dimerix (ASX:DXB), the US Food & Drug Administration (FDA) has delivered the kidney disease drug developer a concession on endpoints for its ongoing phase III trial. The FDA's stance not only means that the endpoints are more likely to be achieved, reducing risk. It also means the company could win accelerated FDA marketing approval before the study has completed. 'That sparked a lot of interest in the sector because suddenly the trials are more manageable,' says Dimerix chief Dr Nina Webster. The 286-patient study is testing Dimerix's candidate DMX-200 for the regressive focal segmental glomerulosclerosis (FSGS). A rare – but not ultra rare – disease, FSGS usually results in end-stage kidney failure. Endpoints have delayed the endgame Previously, the FDA had set an endpoint of how well a drug preserves kidney function. But this meant a trial had to track the patient to kidney failure or death, which could take years. This makes a trial too long and too costly. 'In rare diseases, no-one is going to do these studies,' Webster says. About five years ago the FDA became more amenable to the use of 'surrogate' endpoints These are measures that substitute a true clinical endpoint to expedite drug development. The FDA allowed the use of the kidney function biomarker, called estimated global filtration rate (eGFR). Under the dainty banner of 'Parasol' – and, no it's not an umbrella group – experts advised the use of proteinuria as a further alternative endpoint for FSGS. Proteinuria is kidney proteins seeping into the urine, while eGFR is the rate at which the spuds can cleanse blood. If proteinuria is present and the eGFR is not up to scratch, they are sure signs the kidneys are not working as they should. Conversely, if a drug reduces proteinuria or the eGFR 'slope rate' – the rate of decline – it is accepted as being effective. Parasol promises faster Action Dubbed Action 3, the Dimerix trial involves two years' treatment, as measured against placebo. The study is due to complete in 2027 when the last patients have been treated. But Dimerix now is working with Parasol to establish the exact surrogate endpoints required to front the FDA for accelerated marketing approval. Expedited approval is as allowed for some orphan drugs, such as DMX-200. 'The full study is for two years and that doesn't change,' Webster says. 'Th question is whether we can get interim approval and go to market earlier.' One possibility is that proteinuria alone could be the accepted endpoint, given proteinuria and eGFR appear to point to the same thing. That is: deteriorating kidneys. Dr Webster says an accelerated endpoint must reasonably predict the outcome of the trial. 'The question is, what do we need to see at point X to prove the end at point Y? Parasol is working with us on that. 'We're collecting all of our data on eGFR and proteinuria anyway, so it gives us a lot of flexibility in the program.' (Other geographies such as Japan and Europe still require an eGFR endpoint). Surrogate change spurs others … The FDA's stance on surrogate endpoints could be a double-edged sword for Dimerix, as it also provides succour to potential rivals. In this vein, a drug called sparsentan (brand name Filspari ) won FDA approval for a kidney condition called IgA nephropathy. The drug failed its Phase III endpoint for eGFR. But now its owner Travere Therapeutics is having a crack at FDA marketing approval for FSGS using a proteinuria endpoint. The data from the supportive trial was unblinded, which means the study custodians can't change the endpoints retrospectively. 'But the FDA is in a hard spot with this one because is an area of such high unmet need,' Webster says. 'These patients currently have limited treatment options and Filspari looks like it is doing something for them. 'We are waiting with bated breath in the hope that Filspari is approved and gives hope to these patients.' Travere has licensed the European and local sparsentan rights to our own CSL (ASX:CSL). … but we're friends, not rivals Webster says rather than rivalling DMX-200, sparsentan could be used in unison. An angiotensin receptor, sparsentan targets high blood pressure – a key cause of kidney disease in the first place. (High blood pressure causes inflammation which causes scarring and cell death). Thus, sparsentan needs to be better than the current blood pressure medication. But DMX-200 works on the secondary inflammatory pathway, with the patients already on blood pressure meds. 'It's not apples for apples with study design, which is why we are compared against the placebo and not a comparator,' Webster says. In effect, DMX-200 faces a lower comparative hurdle. 'Our drug is complementary, not competitive,' Webster says. Data 'peek' hints at trial success While a trial result is never certain, Dimerix is confident it won't meet the fate of Opthea or Percheron Therapeutics (ASX:PER). (The latter's neurological disease trial also failed to meet primary endpoints). One reason is that the Action 3 trial already has been subject to a blinded interim analysis by an arm's length expert committee, which peeked at the data. 'Blinded' means that Dimerix, the trial investigators and the patients don't know the results. In March last year the 72-patient analysis reported that DMX-200 worked better than placebo. As per protocol, the experts did not disclose the extent of this efficacy. But it was enough for the company to know that it's on the right track. 'We just know at that point in time, we were doing better and that if we carry on that trajectory, we have a shot at the endpoint,' Webster says. 'That was a big moment for us, because we wanted to confirm something similar to our smaller phase II study in a larger cohort of patients.' FDA approval could come sooner rather than later Dimerix has received over $65 million of cash, courtesy of four distribution deals that may deliver up to $1.4 billion of milestone payments plus royalties. While a further capital raising is a case of 'never say never', it's unlikely. Naturally, most of the milestones are back ended to achievements such as phase III success and FDA approval. But with accelerated approval possible after the interim analysis, the latter might be sooner than investors think. Many drug developers view the Trump Ascendancy Mark Two with trepidation. In contrast, Webster notes Trump nominated kidney disease as a key health priority in his first stab at POTUS. The financial motive alone is compelling, in that dialysis costs the US health system around US$125 billion annually. 'We are in the sweet spot of being a rare disease (with pricing benefits) and having the potential to reduce US healthcare costs,' Webster says.

More than 14 million people could die from US foreign aid cuts, study finds
More than 14 million people could die from US foreign aid cuts, study finds

ABC News

time2 days ago

  • ABC News

More than 14 million people could die from US foreign aid cuts, study finds

More than 14 million of the world's most vulnerable people, a third of them small children, could die because of Donald Trump administration's dismantling of US foreign aid, research has projected. The study in the prestigious Lancet journal was published on Tuesday as world and business leaders gather for a UN conference in Spain this week hoping to bolster the reeling aid sector. The US Agency for International Development (USAID) had provided over 40 per cent of global humanitarian funding until Mr Trump returned to the White House in January. Two weeks later, Mr Trump's then-close advisor, Elon Musk, boasted of having put the agency "through the woodchipper". The funding cuts "risk abruptly halting, and even reversing, two decades of progress in health among vulnerable populations," warned study co-author Davide Rasella, a researcher at the Barcelona Institute for Global Health (ISGlobal). "For many low- and middle-income countries, the resulting shock would be comparable in scale to a global pandemic or a major armed conflict," he said in a statement. Looking back over data from 133 nations, the international team of researchers estimated that USAID funding had prevented 91 million deaths in developing countries between 2001 and 2021. They also used modelling to project how funding being slashed by 83 per cent — the figure announced by the United States government earlier this year — could affect death rates. The cuts could lead to more than 14 million avoidable deaths by 2030, the projections found. That number included over 4.5 million children under the age of five — or about 700,000 child deaths a year. For comparison, about 10 million soldiers are estimated to have been killed during World War I. Programmes supported by USAID were linked to a 15 per cent decrease in deaths from all causes, the researchers found. For children under five, the drop in deaths was twice as steep at 32 per cent. USAID funding was found to be particularly effective at staving off preventable deaths from disease. There were 65 per cent fewer deaths from HIV/AIDS in countries receiving a high level of support compared to those with little or no USAID funding, the study found. Deaths from malaria and neglected tropical diseases were similarly cut in half. After USAID was gutted, several other major donors including Germany, the UK and France followed suit in announcing plans to slash their foreign aid budgets. These aid reductions, particularly in the European Union, could lead to "even more additional deaths in the coming years," study co-author Caterina Monti of ISGlobal said. But the grim projections for deaths were based on the current amount of pledged aid. Researchers emphasised this could rapidly come down if the situation changes. Dozens of world leaders are meeting in the Spanish city of Seville this week for the biggest aid conference in a decade. The US, however, will not attend. "Now is the time to scale up, not scale back," Professor Rasella said. Before its funding was slashed, USAID represented 0.3 per cent of all US federal spending. "US citizens contribute about 17 cents per day to USAID, around $64 per year," said study co-author James Macinko of the University of California, Los Angeles. "I think most people would support continued USAID funding if they knew just how effective such a small contribution can be to saving millions of lives." AFP

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store